Total
0
Shares
Archer Materials (ASX:AXE) - CEO, Mohammad Choucair
CEO, Mohammad Choucair
Source: Archer Materials
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Archer Materials (AXE) has seen its biochip technology filed in the US and assigned a US application number
  • Archer says it considers this a key strategic move to protect and commercialise its intellectual property
  • Meanwhile, patent applications for Archer’s 12CQ chip are progressing in later stages of the patent granting procedures in the US and Europe
  • Archer Materials are up 19.4 per cent to trade at $2.83 at 12:52 pm AEST

Archer Materials (AXE) has seen its biochip technology filed for a patent in the US and assigned a US application number.

Archer is a technology company developing and commercialising advanced semiconductor devices, including chips relevant to quantum computing and medical diagnostics.

The company’s 100 per cent owned patent application, related to its graphene-based biochip technology, has progressed to the national phase of the patent granting procedure. The company says this allows the company to pursue and achieve patent granting in the US for the respective patent application.    

Archer says it considers this move key to protecting and commercialising its IP in an important jurisdiction.

A national phase entry has also been sought by the company in Australia. As patents are only granted in each country by the relevant national patent office, the national phase entry is a key requirement in the process for the granting of a patent internationally.

This follows the news that Archer expanded its access to institutional deep tech infrastructure and hired new personnel to develop its biochip technology.

Meanwhile, patent applications for Archer’s 12CQ chip are progressing in later stages of the patent granting procedures in the US and Europe.

Archer Materials were up 19.4 per cent to trade at $2.83 at 12:52 pm AEST.

AXE by the numbers
More From The Market Herald
Audio Pixels (ASX:AKP) - Chair, Fred Bart

" Audio Pixels (ASX:AKP) finds tech can extend to $30b earphone market

Audio Pixels (AKP) has found its existing digital sound reconstruction (DSR) loudspeaker technologies can extend for use in earphones and headphones.
Bluechiip (ASX:BCT) - Managing Director, Andrew McLellan

" Bluechiip (ASX:BCT) to customise tech for assisted fertility market

Sample technology company Bluechiip (BCT) has signed a two-year licence and development agreement with FUJIFILM Irvine Scientific (FISI).
Biogene Technology (ASX:BGT) - CEO, Richard Jagger

" Bio-Gene (ASX:BGT) shares close green on new commercial deal

Bio-Gene Technology (BGT) has executed a licence and development agreement with Evergreen Garden Care.
Beam Communications (ASX:BCC) - Chairman, Simon Wallace

" Beam Communications (ASX:BCC) receives orders for 12,000 ZOLEO units

Beam Communications (BCC) has received orders for 12,000 extra ZOLEO devices manufactured under its joint venture entity.